These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18607801)

  • 21. A general approach for sample size and statistical power calculations assessing of interventions using a mixture model in the presence of detection limits.
    Nie L; Chu H; Cole SR
    Contemp Clin Trials; 2006 Oct; 27(5):483-91. PubMed ID: 16769254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of multinomial and binomial proportion methods for analysis of multinomial count data.
    Galyean ML; Wester DB
    J Anim Sci; 2010 Oct; 88(10):3452-63. PubMed ID: 20601524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sample size calculations for population pharmacodynamic experiments involving repeated dichotomous observations.
    Ogungbenro K; Aarons L
    J Biopharm Stat; 2008; 18(6):1212-27. PubMed ID: 18991118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
    Lachin JM
    Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statistical inference of risk difference in K correlated 2 x 2 tables with structural zero.
    Wang SF; Tang NS; Zhang B; Wang XR
    Pharm Stat; 2009; 8(4):317-32. PubMed ID: 19152229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of one-sample two-sided sequential t-tests for application in epidemiological studies.
    van der Tweel I; Kaaks R; van Noord PA
    Stat Med; 1996 Dec; 15(24):2781-95. PubMed ID: 8981686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inference on treatment effects for targeted clinical trials under enrichment design.
    Liu JP; Lin JR; Chow SC
    Pharm Stat; 2009; 8(4):356-70. PubMed ID: 19180519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninferiority tests based on concordance correlation coefficient for assessment of the agreement for gene expression data from microarray experiments.
    Liao CT; Lin CY; Liu JP
    J Biopharm Stat; 2007; 17(2):309-27. PubMed ID: 17365226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statistical methods for haplotype-based matched case-control association studies.
    Zhang H; Zhang H; Li Z; Zheng G
    Genet Epidemiol; 2007 May; 31(4):316-26. PubMed ID: 17285622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of equivalence using a concordance correlation coefficient in a repeated measurements design.
    Quiroz J
    J Biopharm Stat; 2005; 15(6):913-28. PubMed ID: 16279351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing genomewide statistical significance in linkage studies.
    Lin DY; Zou F
    Genet Epidemiol; 2004 Nov; 27(3):202-14. PubMed ID: 15389929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statistical test for evaluation of biosimilarity in variability of follow-on biologics.
    Hsieh TC; Chow SC; Liu JP; Hsiao CF; Chi E
    J Biopharm Stat; 2010 Jan; 20(1):75-89. PubMed ID: 20077250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linearity study of blood calcium test.
    Zhou Q; Xu J; Xie W; Li S; Li X
    Clin Lab; 2011; 57(5-6):327-31. PubMed ID: 21755822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined linkage and association mapping of quantitative trait Loci with missing completely at random genotype data.
    Fan R; Liu L; Jung J; Zhong M
    Behav Genet; 2008 May; 38(3):316-36. PubMed ID: 18306033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two-sided tolerance intervals for balanced and unbalanced random effects models.
    Hoffman D; Kringle R
    J Biopharm Stat; 2005; 15(2):283-93. PubMed ID: 15796296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Empirical Bayes screening of many p-values with applications to microarray studies.
    Datta S; Datta S
    Bioinformatics; 2005 May; 21(9):1987-94. PubMed ID: 15691856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methods for one-sided testing of the difference between proportions and sample size considerations related to non-inferiority clinical trials.
    Dann RS; Koch GG
    Pharm Stat; 2008; 7(2):130-41. PubMed ID: 17526060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sample size calculation for the weighted rank statistics with paired survival data.
    Jung SH
    Stat Med; 2008 Jul; 27(17):3350-65. PubMed ID: 18205148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
    Tsong Y; Zhang J
    J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Test homogeneity of risk difference across subgroups in clinical trials.
    Zhang L; Yang H; Cho I
    J Biopharm Stat; 2009; 19(1):67-76. PubMed ID: 19127467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.